Pharmaceutical Industry

Page 10 of 100

France’s top-selling painkiller may be sold to the U.S. and is causing the nation a splitting headache
Retail

France’s top-selling painkiller may be sold to the U.S. and is causing the nation a splitting headache

By Jurgen Hecker and AFP
October 15, 2024
Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis
Commentary

Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis

By Jeffrey Sonnenfeld and Steven Tian
October 10, 2024
Despite the ubiquitousness of injectable GLP-1 drugs indicated for people with obesity, most Americans wouldn’t take them, according to a September 2024 survey from the Physicians Committee for Responsible Medicine.
Health

Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says

By
October 10, 2024
British pharma giant GSK strikes $2.3 billion deal to put an end to 80,000 U.S. lawsuits
Retail

British pharma giant GSK strikes $2.3 billion deal to put an end to 80,000 U.S. lawsuits

By
October 10, 2024
Some businesses are now backtracking on DEI. Biopharma cannot afford to and must remain resolute
Commentary

Some businesses are now backtracking on DEI. Biopharma cannot afford to and must remain resolute

By
October 9, 2024
Martin Shkreli holds his head, as if he knows how much of a headache it's going to be to convince the Supreme Court to overturn his case
Politics

Martin Shkreli gets snubbed by the Supreme Court and must return millions he reaped from jacking up the price of a lifesaving drug

By Lindsay Whitehurst and The Associated Press
October 7, 2024
Google DeepMind director of strategic initiatives, Terra Terwilliger, speaking onstage at Coins2Day's COO Summit.
Tech

Google DeepMind exec says AI will increase efficiency so much it’s expected to handle 50% of info requests in its legal department

By
October 7, 2024
Albert Bourla puts his palm flat on tup of his other hand, rolled up in a fist, as he sits and listens to a question onstage at a conference.
Finance

Pfizer stock surges 3% after activist Starboard takes $1 billion stake, taps former execs

By
October 7, 2024
balding head
Health

Hair loss drug probed in Europe over link to suicidal thoughts

By Ashleigh Furlong and Bloomberg
October 4, 2024
woman sitting in the dark looking at a light-therapy box
Mind

Bright light therapy used for Seasonal Affective Disorder can help treat other depressions too

By
October 2, 2024
Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk A/S, during an interview at the company's headquarters in Bagsvaerd, Denmark, on Monday, June 12, 2023.
Health

Novo Nordisk CEO takes aim at U.S. healthcare as he defends Ozempic pricing to Bernie Sanders

By
September 24, 2024
Novo Nordisk’s $570 billion valuation is more than Denmark’s GDP—but PM isn’t worried about a ‘Nokia risk’
Finance

Novo Nordisk’s $570 billion valuation is more than Denmark’s GDP—but PM isn’t worried about a ‘Nokia risk’

By Sara Sjolin, Sanne Wass, Oliver Crook and Bloomberg
September 23, 2024
COVID-19 symptoms can be mild, severe, or nonexistent, according to the Centers for Disease Control and Prevention—and can appear as late as two weeks after you’ve been exposed to the virus.
Health

Could it be COVID? Here are the symptoms to watch out for in 2024

By
September 21, 2024
Mark Cuban says he’s not going through a midlife crisis but would buy X and Fox News if he could
Leadership

Mark Cuban says he’s not going through a midlife crisis but would buy X and Fox News if he could

By
September 16, 2024
Eli Lilly’s new CFO is a 23-year company veteran—showing how pharma firms rely on a ‘deep bench of qualified talent’
Newsletters

Eli Lilly’s new CFO is a 23-year company veteran—showing how pharma firms rely on a ‘deep bench of qualified talent’

By
September 10, 2024

Most Popular